Featured

[Special Report] Trademark filing and litigation trends 2024: Insights and opportunities

Robert Reading

Director, Corporate Strategy, Content at Clarivate

Biopharma
What a string of semaglutide biosimilars could mean for Mainland China
Academia and Government
Introducing the Clarivate Academic AI Platform
Clarivate Insights
December 10, 2020
Intellectual Property
October 6, 2020
Intellectual Property
September 29, 2020
Intellectual Property
September 10, 2020
Intellectual Property
September 3, 2020